Turkey will receive the first batch of JAB, which is 91.25 percent effective in the ARZU Yildirim nurse (center) administers a dose of China Sinovirus vaccines during phase III clinical trials in The Acibadem Hospital in Istanbul, Turkey, on Monday. Emrah Gurel / AP

Ankara-Turkey will receive its first shipment of China Sinovac CORONAVIRUS vaccines in a few days as preliminary domestic tests showed that it was 91 percent cash, becoming the last country to welcome the Chinese scientific medical advances.

"We are sure that the vaccine is effective and safe for Turkish people," said Health Minister Fahrettin Koca on Thursday at a press conference.

The initial protection rate of the vaccine is 91.25 percent and there is no major side - infects were seen during their judgment, Koca said.

It was expected that the first shipment of 3 million doses of the Chinese vaccine will reach Turkey on Monday after the Turkish government signed an agreement to buy up to 50 million. Dose. All these doses will eventually arrive in the country at the end of February.

The primary group to vaccinate will be the health personnel and the jabs could be applied to about 1.5 million or even 2 million people daily, Koca said, adding that it will be among the pioneers in taking Chinese vaccine.

In Asia, said Bahrain on December 13, had approved a VACCOT-19 vaccine developed by China National Pharmaceutical Group (Sinopharm) and released online registration for citizens and residents.

A declaration of the National Health Regulation Authority did not specify which two vaccine being developed by SinoFarm had been followed up, but cited data from phase III clinical trials that showed an efficiency rate Of 86 percent in which Bahrain had participated.

The Bahrain Ministry of Health said in a statement and in your account account that citizens and residents over 18 could register online to receive the vaccine for free.

The data cited were the same as announced earlier this month by the United Arab Emirates of an interim analysis of late stage clinical trials for an inactivated vaccine developed by the Beijing Institute of Biological Product, a Unit of the China National Biotec Group of SinopoM, or CNBG.

Malaysia said that the government is now in the final negotiations with manufacturers based on China, Sinovac and Cansino to ensure a dose of the vaccine to cover more of its population.

'a historical day'

In Latin America, the State Bizancan Institute, on Wednesday, the Coronavac vaccine developed by the effectiveness levels achieved by Sinovac of China Against the Coronavirus required by the World Health Organization in trials with 13,000 Brazilian volunteers.

The data corroborated that the vaccine is "the safest in the market" and has achieved superiority in the effectiveness required by the WHO Health Regulatory Agency (ANVISA), said Dimas Covas, Director of the institute. .

"We have reached the level of effectiveness that allows us to request the registration for the use of vaccine emergency both here and in China," Covas said.

"It's a historical day for Brazilian science because of the hope that brings the Brazilians."

The Brazilian Ministry of Health is also expected to have at least 150 million doses of Vaccines against Covid-19 available in the first half of 2021, with a third or more from Sinovac.

Arnaldo Medeiros, an official of the Ministry of Health, said an initial agreement on Tuesday to acquire 46 million doses of the vaccine developed by Sinovac, will soon be expanded to 100 million doses.

In Mexico, the Coronavirus vaccine developed by the biological of Cansino de China will be presented on Tuesday by review by the Mexican health regulator COFEPRIS for application, Mexico Foreign Minister Marcelo Ebrad said .

In Africa, Egypt received the first batch of the Vaccine against Chinese Coronavirus on December 11 to help fight against the Covid-19 epidemi


Image of How to find a teaching job in Universities in China
Rate and Comment
Image of 1st LD-Writethru: Chinese shares close mixed on Monday
1st LD-Writethru: Chinese shares close mixed on Monday

Beijing, September 13 (Xinhua) - Chinese shares were mixed mixed on Monday, with the index composed of Shanghai reference, 0.33 percent, at 3,715.37

Read more →




Already have an account? Login here

contact us


Add Job Alert